Enfamil/Similac Compositional Comparisons Should Be Revised – NAD
This article was originally published in The Tan Sheet
Executive Summary
Mead Johnson should discontinue or modify compositional comparisons made between its Enfamil LIPIL and Ross Products' Similac Advance infant formulas, according to the National Advertising Division
You may also be interested in...
Nestle DHA, ARA Infant Formula Claims Must Be “Compositional” – NAD
Nestle may continue to make "limited" claims regarding DHA and ARA in advertising for its Good Start Supreme DHA & ARA infant formula, according to the National Advertising Division
Nestle DHA, ARA Infant Formula Claims Must Be “Compositional” – NAD
Nestle may continue to make "limited" claims regarding DHA and ARA in advertising for its Good Start Supreme DHA & ARA infant formula, according to the National Advertising Division
Nestle DHA, ARA Infant Formula Claims Must Be “Compositional” – NAD
Nestle may continue to make "limited" claims regarding DHA and ARA in advertising for its Good Start Supreme DHA & ARA infant formula, according to the National Advertising Division